By Justin Petrone

Agilent Technologies has found yet another use for its microarray manufacturing resources. The company is now relying on its array fabrication facility, known internally as "the fab," to produce its new line of SureFISH oligonucleotide probes for fluorescence in situ hybridization experiments. And since launching the menu of probes last month, Agilent has been targeting SureFISH to its array customers, many of whom use FISH to validate array findings, according to a company executive.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.